Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

EVH vs PINC vs ALHC vs HQY vs TDOC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
EVH
Evolent Health, Inc.

Medical - Healthcare Information Services

HealthcareNYSE • US
Market Cap$488M
5Y Perf.-78.8%
PINC
Premier, Inc.

Medical - Healthcare Information Services

HealthcareNASDAQ • US
Market Cap$2.34B
5Y Perf.-16.9%
ALHC
Alignment Healthcare, Inc.

Medical - Healthcare Plans

HealthcareNASDAQ • US
Market Cap$3.73B
5Y Perf.-16.8%
HQY
HealthEquity, Inc.

Medical - Healthcare Information Services

HealthcareNASDAQ • US
Market Cap$7.14B
5Y Perf.+23.5%
TDOC
Teladoc Health, Inc.

Medical - Healthcare Information Services

HealthcareNYSE • US
Market Cap$1.26B
5Y Perf.-96.2%

EVH vs PINC vs ALHC vs HQY vs TDOC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
EVH logoEVH
PINC logoPINC
ALHC logoALHC
HQY logoHQY
TDOC logoTDOC
IndustryMedical - Healthcare Information ServicesMedical - Healthcare Information ServicesMedical - Healthcare PlansMedical - Healthcare Information ServicesMedical - Healthcare Information Services
Market Cap$488M$2.34B$3.73B$7.14B$1.26B
Revenue (TTM)$1.89B$1.00B$4.26B$1.31B$2.51B
Net Income (TTM)$-497M$-24M$20M$215M$-171M
Gross Margin14.0%72.6%9.0%69.5%65.6%
Operating Margin-27.4%-0.0%0.8%24.6%-7.6%
Forward P/E31.2x20.8x140.9x21.2x
Total Debt$990M$282M$338M$44M$1.04B
Cash & Equiv.$152M$84M$578M$319M$781M

EVH vs PINC vs ALHC vs HQY vs TDOCLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

EVH
PINC
ALHC
HQY
TDOC
StockMar 21May 26Return
Evolent Health, Inc. (EVH)10021.2-78.8%
Premier, Inc. (PINC)10083.1-16.9%
Alignment Healthcar… (ALHC)10083.2-16.8%
HealthEquity, Inc. (HQY)100123.5+23.5%
Teladoc Health, Inc. (TDOC)1003.8-96.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: EVH vs PINC vs ALHC vs HQY vs TDOC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: PINC leads in 4 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and capital preservation and lower volatility. HealthEquity, Inc. is the stronger pick specifically for profitability and margin quality and operational efficiency and capital deployment. ALHC also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
EVH
Evolent Health, Inc.
The Income Angle

EVH lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
PINC
Premier, Inc.
The Income Pick

PINC carries the broadest edge in this set and is the clearest fit for income & stability and defensive.

  • Dividend streak 1 yrs, beta 0.07, yield 3.0%
  • Beta 0.07, yield 3.0%, current ratio 0.64x
  • Lower P/E (20.8x vs 21.2x)
  • Beta 0.07 vs TDOC's 1.91, lower leverage
Best for: income & stability and defensive
ALHC
Alignment Healthcare, Inc.
The Insurance Pick

ALHC ranks third and is worth considering specifically for growth exposure.

  • Rev growth 46.1%, EPS growth 99.4%, 3Y rev CAGR 40.2%
  • 46.1% revenue growth vs EVH's -26.6%
Best for: growth exposure
HQY
HealthEquity, Inc.
The Long-Run Compounder

HQY is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.

  • 228.2% 10Y total return vs ALHC's 5.4%
  • Lower volatility, beta 1.04, Low D/E 2.1%, current ratio 3.27x
  • 16.4% margin vs EVH's -26.3%
  • 6.3% ROA vs EVH's -22.8%, ROIC 10.2% vs -0.2%
Best for: long-term compounding and sleep-well-at-night
TDOC
Teladoc Health, Inc.
The Healthcare Pick

Among these 5 stocks, TDOC doesn't own a clear edge in any measured category.

Best for: healthcare exposure
See the full category breakdown
CategoryWinnerWhy
GrowthALHC logoALHC46.1% revenue growth vs EVH's -26.6%
ValuePINC logoPINCLower P/E (20.8x vs 21.2x)
Quality / MarginsHQY logoHQY16.4% margin vs EVH's -26.3%
Stability / SafetyPINC logoPINCBeta 0.07 vs TDOC's 1.91, lower leverage
DividendsPINC logoPINC3.0% yield, 1-year raise streak, vs EVH's 2.3%, (3 stocks pay no dividend)
Momentum (1Y)PINC logoPINC+24.0% vs EVH's -59.0%
Efficiency (ROA)HQY logoHQY6.3% ROA vs EVH's -22.8%, ROIC 10.2% vs -0.2%

EVH vs PINC vs ALHC vs HQY vs TDOC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

EVHEvolent Health, Inc.
FY 2025
Reportable Segment
100.0%$1.9B
PINCPremier, Inc.
FY 2025
Administrative Fees
100.0%$556M
ALHCAlignment Healthcare, Inc.
FY 2023
Health Care, Premium
92.6%$1.7B
Health Care Capitation
7.4%$133M
HQYHealthEquity, Inc.
FY 2026
Financial Service, Other
48.5%$637M
Service
36.9%$485M
Credit and Debit Card
14.6%$192M
TDOCTeladoc Health, Inc.
FY 2025
Other
100.0%$438M

EVH vs PINC vs ALHC vs HQY vs TDOC — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLHQYLAGGINGTDOC

Income & Cash Flow (Last 12 Months)

HQY leads this category, winning 3 of 6 comparable metrics.

ALHC is the larger business by revenue, generating $4.3B annually — 4.2x PINC's $1.0B. HQY is the more profitable business, keeping 16.4% of every revenue dollar as net income compared to EVH's -26.3%. On growth, ALHC holds the edge at +33.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricEVH logoEVHEvolent Health, I…PINC logoPINCPremier, Inc.ALHC logoALHCAlignment Healthc…HQY logoHQYHealthEquity, Inc.TDOC logoTDOCTeladoc Health, I…
RevenueTrailing 12 months$1.9B$1.0B$4.3B$1.3B$2.5B
EBITDAEarnings before interest/tax-$403M$118M$66M$322M$42M
Net IncomeAfter-tax profit-$497M-$24M$20M$215M-$171M
Free Cash FlowCash after capex$1M$265M$237M$439M$251M
Gross MarginGross profit ÷ Revenue+14.0%+72.6%+9.0%+69.5%+65.6%
Operating MarginEBIT ÷ Revenue-27.4%-0.0%+0.8%+24.6%-7.6%
Net MarginNet income ÷ Revenue-26.3%-2.4%+0.5%+16.4%-6.8%
FCF MarginFCF ÷ Revenue+0.1%+26.4%+5.6%+33.4%+10.0%
Rev. Growth (YoY)Latest quarter vs prior year+2.6%-3.3%+33.3%+7.3%-2.5%
EPS Growth (YoY)Latest quarter vs prior year+61.9%-70.0%+2.1%+93.3%+32.1%
HQY leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

Evenly matched — EVH and TDOC each lead in 2 of 6 comparable metrics.

At 34.1x trailing earnings, HQY trades at a 73% valuation discount to PINC's 128.5x P/E. On an enterprise value basis, EVH's 11.9x EV/EBITDA is more attractive than ALHC's 77.1x.

MetricEVH logoEVHEvolent Health, I…PINC logoPINCPremier, Inc.ALHC logoALHCAlignment Healthc…HQY logoHQYHealthEquity, Inc.TDOC logoTDOCTeladoc Health, I…
Market CapShares × price$488M$2.3B$3.7B$7.1B$1.3B
Enterprise ValueMkt cap + debt − cash$1.3B$2.5B$3.5B$6.9B$1.5B
Trailing P/EPrice ÷ TTM EPS-0.84x128.45x-4932.43x34.14x-6.11x
Forward P/EPrice ÷ next-FY EPS est.31.17x20.79x140.93x21.23x
PEG RatioP/E ÷ EPS growth rate0.41x
EV / EBITDAEnterprise value multiple11.90x21.35x77.12x21.29x15.13x
Price / SalesMarket cap ÷ Revenue0.26x2.31x0.94x5.44x0.50x
Price / BookPrice ÷ Book value/share1.18x1.70x20.16x3.49x0.89x
Price / FCFMarket cap ÷ FCF102.63x7.33x32.95x15.69x4.40x
Evenly matched — EVH and TDOC each lead in 2 of 6 comparable metrics.

Profitability & Efficiency

HQY leads this category, winning 8 of 9 comparable metrics.

ALHC delivers a 11.5% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-78 for EVH. HQY carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to EVH's 2.38x. On the Piotroski fundamental quality scale (0–9), HQY scores 9/9 vs PINC's 4/9, reflecting strong financial health.

MetricEVH logoEVHEvolent Health, I…PINC logoPINCPremier, Inc.ALHC logoALHCAlignment Healthc…HQY logoHQYHealthEquity, Inc.TDOC logoTDOCTeladoc Health, I…
ROE (TTM)Return on equity-77.9%-1.6%+11.5%+10.1%-12.4%
ROA (TTM)Return on assets-22.8%-0.8%+1.8%+6.3%-5.9%
ROICReturn on invested capital-0.2%+0.0%+10.2%-11.5%
ROCEReturn on capital employed-0.3%+0.0%+2.9%+9.8%-10.0%
Piotroski ScoreFundamental quality 0–954696
Debt / EquityFinancial leverage2.38x0.18x1.89x0.02x0.75x
Net DebtTotal debt minus cash$838M$198M-$240M-$275M$259M
Cash & Equiv.Liquid assets$152M$84M$578M$319M$781M
Total DebtShort + long-term debt$990M$282M$338M$44M$1.0B
Interest CoverageEBIT ÷ Interest expense-14.04x1.13x1.27x5.64x-8.76x
HQY leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — ALHC and HQY each lead in 2 of 6 comparable metrics.

A $10,000 investment in HQY five years ago would be worth $11,269 today (with dividends reinvested), compared to $461 for TDOC. Over the past 12 months, PINC leads with a +24.0% total return vs EVH's -59.0%. The 3-year compound annual growth rate (CAGR) favors ALHC at 36.2% vs EVH's -50.2% — a key indicator of consistent wealth creation.

MetricEVH logoEVHEvolent Health, I…PINC logoPINCPremier, Inc.ALHC logoALHCAlignment Healthc…HQY logoHQYHealthEquity, Inc.TDOC logoTDOCTeladoc Health, I…
YTD ReturnYear-to-date+10.0%-9.7%-7.8%-1.3%
1-Year ReturnPast 12 months-59.0%+24.0%+17.6%-8.4%+1.5%
3-Year ReturnCumulative with dividends-87.7%+14.8%+152.4%+56.0%-73.3%
5-Year ReturnCumulative with dividends-78.4%-9.2%-22.7%+12.7%-95.4%
10-Year ReturnCumulative with dividends-63.6%-4.6%+5.4%+228.2%-41.1%
CAGR (3Y)Annualised 3-year return-50.2%+4.7%+36.2%+16.0%-35.6%
Evenly matched — ALHC and HQY each lead in 2 of 6 comparable metrics.

Risk & Volatility

PINC leads this category, winning 2 of 2 comparable metrics.

PINC is the less volatile stock with a 0.07 beta — it tends to amplify market swings less than TDOC's 1.91 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PINC currently trades 98.2% from its 52-week high vs EVH's 35.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricEVH logoEVHEvolent Health, I…PINC logoPINCPremier, Inc.ALHC logoALHCAlignment Healthc…HQY logoHQYHealthEquity, Inc.TDOC logoTDOCTeladoc Health, I…
Beta (5Y)Sensitivity to S&P 5001.21x0.07x0.75x1.04x1.91x
52-Week HighHighest price in past year$12.07$28.79$23.87$116.65$9.77
52-Week LowLowest price in past year$2.10$20.62$11.63$72.90$4.40
% of 52W HighCurrent price vs 52-week peak+35.5%+98.2%+76.5%+72.0%+71.2%
RSI (14)Momentum oscillator 0–10068.065.037.352.774.1
Avg Volume (50D)Average daily shares traded3.0M03.6M876K5.5M
PINC leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — PINC and HQY each lead in 1 of 2 comparable metrics.

Analyst consensus: EVH as "Buy", PINC as "Hold", ALHC as "Buy", HQY as "Buy", TDOC as "Hold". Consensus price targets imply 49.1% upside for EVH (target: $6) vs -0.0% for PINC (target: $28). For income investors, PINC offers the higher dividend yield at 2.98% vs EVH's 2.28%.

MetricEVH logoEVHEvolent Health, I…PINC logoPINCPremier, Inc.ALHC logoALHCAlignment Healthc…HQY logoHQYHealthEquity, Inc.TDOC logoTDOCTeladoc Health, I…
Analyst RatingConsensus buy/hold/sellBuyHoldBuyBuyHold
Price TargetConsensus 12-month target$6.38$28.25$24.83$109.89$7.58
# AnalystsCovering analysts2931162742
Dividend YieldAnnual dividend ÷ price+2.3%+3.0%
Dividend StreakConsecutive years of raises012
Dividend / ShareAnnual DPS$0.10$0.84
Buyback YieldShare repurchases ÷ mkt cap+8.2%+17.1%0.0%+4.2%0.0%
Evenly matched — PINC and HQY each lead in 1 of 2 comparable metrics.
Key Takeaway

HQY leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PINC leads in 1 (Risk & Volatility). 3 tied.

Best OverallHealthEquity, Inc. (HQY)Leads 2 of 6 categories
Loading custom metrics...

EVH vs PINC vs ALHC vs HQY vs TDOC: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is EVH or PINC or ALHC or HQY or TDOC a better buy right now?

For growth investors, Alignment Healthcare, Inc.

(ALHC) is the stronger pick with 46. 1% revenue growth year-over-year, versus -26. 6% for Evolent Health, Inc. (EVH). HealthEquity, Inc. (HQY) offers the better valuation at 34. 1x trailing P/E (21. 2x forward), making it the more compelling value choice. Analysts rate Evolent Health, Inc. (EVH) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — EVH or PINC or ALHC or HQY or TDOC?

On trailing P/E, HealthEquity, Inc.

(HQY) is the cheapest at 34. 1x versus Premier, Inc. at 128. 5x. On forward P/E, Premier, Inc. is actually cheaper at 20. 8x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — EVH or PINC or ALHC or HQY or TDOC?

Over the past 5 years, HealthEquity, Inc.

(HQY) delivered a total return of +12. 7%, compared to -95. 4% for Teladoc Health, Inc. (TDOC). Over 10 years, the gap is even starker: HQY returned +228. 2% versus EVH's -63. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — EVH or PINC or ALHC or HQY or TDOC?

By beta (market sensitivity over 5 years), Premier, Inc.

(PINC) is the lower-risk stock at 0. 07β versus Teladoc Health, Inc. 's 1. 91β — meaning TDOC is approximately 2593% more volatile than PINC relative to the S&P 500. On balance sheet safety, HealthEquity, Inc. (HQY) carries a lower debt/equity ratio of 2% versus 2% for Evolent Health, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — EVH or PINC or ALHC or HQY or TDOC?

By revenue growth (latest reported year), Alignment Healthcare, Inc.

(ALHC) is pulling ahead at 46. 1% versus -26. 6% for Evolent Health, Inc. (EVH). On earnings-per-share growth, the picture is similar: HealthEquity, Inc. grew EPS 125. 7% year-over-year, compared to -525. 9% for Evolent Health, Inc.. Over a 3-year CAGR, ALHC leads at 40. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — EVH or PINC or ALHC or HQY or TDOC?

HealthEquity, Inc.

(HQY) is the more profitable company, earning 16. 4% net margin versus -28. 5% for Evolent Health, Inc. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HQY leads at 24. 6% versus -10. 4% for TDOC. At the gross margin level — before operating expenses — PINC leads at 73. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is EVH or PINC or ALHC or HQY or TDOC more undervalued right now?

On forward earnings alone, Premier, Inc.

(PINC) trades at 20. 8x forward P/E versus 140. 9x for Alignment Healthcare, Inc. — 120. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EVH: 49. 1% to $6. 38.

08

Which pays a better dividend — EVH or PINC or ALHC or HQY or TDOC?

In this comparison, PINC (3.

0% yield), EVH (2. 3% yield) pay a dividend. ALHC, HQY, TDOC do not pay a meaningful dividend and should not be held primarily for income.

09

Is EVH or PINC or ALHC or HQY or TDOC better for a retirement portfolio?

For long-horizon retirement investors, Premier, Inc.

(PINC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 07), 3. 0% yield). Teladoc Health, Inc. (TDOC) carries a higher beta of 1. 91 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PINC: -4. 6%, TDOC: -41. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between EVH and PINC and ALHC and HQY and TDOC?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: EVH is a small-cap quality compounder stock; PINC is a small-cap quality compounder stock; ALHC is a small-cap high-growth stock; HQY is a small-cap quality compounder stock; TDOC is a small-cap quality compounder stock. EVH, PINC pay a dividend while ALHC, HQY, TDOC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

EVH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Dividend Yield > 0.9%
Run This Screen
Stocks Like

PINC

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 43%
  • Dividend Yield > 1.1%
Run This Screen
Stocks Like

ALHC

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 16%
Run This Screen
Stocks Like

HQY

Steady Growth Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 9%
Run This Screen
Stocks Like

TDOC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 39%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform EVH and PINC and ALHC and HQY and TDOC on the metrics below

Revenue Growth>
%
(EVH: 2.6% · PINC: -3.3%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.